ANDA 85248, held by Watson Labs. Reserpine; Trichlormethiazide.
As of Nov 15, 2026, ANDA 85248 (Trichlormethiazide W/ Reserpine), held by Watson Labs, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Trichlormethiazide W/ Reserpine0.1MG;4MG ยท tablet;oral | Reserpine; Trichlormethiazide | Discontinued |
| Sep 30, 1987 | Supplement 19Manufacturing | Approved | None posted |
| Apr 13, 1983 | Supplement 15Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
